RxDoctor Payments Data

David Fisher

Optometrist · Oviedo, FLNPI 1598875809

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (43.8%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 20 manufacturers reported payments, led by Alcon at 49.0% of the total. Reporting peaked in 2023 at $6,471 and has fallen 60.7% since, to $2,540 in 2025. Among optometrist clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$20,548in general payments, 2019–2025

Across 194 payments — averaging $105.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Alcon$10K
  • Coopervision Inc.$3K
  • Bausch & Lomb, A Division Of Bausch Health US, LLC$2K
  • Visionary Optics LLC$2K
  • Maculogix, Inc.$1K
  • Bausch & Lomb Americas Inc.$1K
  • plus $2K from 14 others
$1,585in research payments, 2019–2025

Across 2 payments — averaging $792.50 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Coopervision Inc.$2K

What the payments were for

  • Consulting fees$1,0505%
  • Speaking & faculty fees$9,00044%
  • Travel & lodging$2,52512%
  • Food & beverage$6,29431%
  • Gifts$1,6608%
  • Entertainment$190%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$20,548 in reported general payments places this provider in the 95th percentile of 3,166 optometrist providers in Florida.

See all optometrist providers in Florida →

Medicare billing

Part B allowed, 2024
$19,080
Medicare patients
93
Services billed
169

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
LumiganBimatoprost17$5,228
Latanoprost17$191

Paid to pharmacies, not to this prescriber.

Other optometrist in Oviedo

See the full list for Florida →

Where these figures come from

Is this you, or does something look wrong? →